Pharmacogenetics of clinical response to risperidone.
Llerena A, Llerena A, Berecz R, Peñas-Lledó E, Süveges A, Fariñas H.
Pharmacogenomics · research support, non-u.s. gov't; review; journal article · DOI 10.2217/pgs.12.201Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för risperidone. Visa hela publikationsregistret
Llerena A, Llerena A, Berecz R, Peñas-Lledó E, Süveges A, Fariñas H.
Pharmacogenomics · research support, non-u.s. gov't; review; journal article · DOI 10.2217/pgs.12.201Peltonen I, Männistö PT.
Basic Clin Pharmacol Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1742-7843.2010.00626.xShioda K, Nisijima K, Yoshino T, Kuboshima K, Iwamura T, Yui K, Kato S.
Neurotoxicology · journal article · DOI 10.1016/j.neuro.2008.07.005Rossi A, Vita A, Tiradritti P, Romeo F.
Int Clin Psychopharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1097/yic.0b013e3282f94905Rendell JM, Geddes JR.
Cochrane Database Syst Rev · research support, non-u.s. gov't; systematic review; journal article · DOI 10.1002/14651858.cd004999.pub2Sajatovic M, Subramoniam M, Fuller MA.
Neuropsychiatr Dis Treat · research-article; journal article · DOI 10.2147/nedt.2006.2.2.127Parellada E, Baeza I, de Pablo J, Martínez G.
J Clin Psychiatry · clinical trial; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.4088/jcp.v65n0310Pajonk FG.
Prog Neuropsychopharmacol Biol Psychiatry · review; journal article · DOI 10.1016/s0278-5846(03)00164-7Harrison TS, Goa KL.
CNS Drugs · review; journal article · DOI 10.2165/00023210-200418020-00005DeVane CL, Nemeroff CB.
J Clin Psychopharmacol · meta-analysis; journal article · DOI 10.1097/00004714-200108000-00008Hesslinger B, Walden J, Normann C.
Pharmacopsychiatry · journal article; case reports · DOI 10.1055/s-2001-15190